372 Followers on Owler
OverviewCompetitorsAcquisitionsFundingNews & Insights

PierianDx Competitors or Alternatives

PierianDx's top competitors include RTL Genomics, Verogen and Swift.

Unlock 19 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

PierianDx's company profile

Mark McDonough

Co-Founder & CEO

76/100
100 - 250
$74.2M
$5M - 25M
  • $74.2M
    $5M - 25M
  • 100 - 250
    $74.2M
  • $5M - 25M
  • 76/100
  • 100 - 250
  • $74.2M
  • $5M - 25M
View ProfileView
1
PierianDx's Competitor - RTL Genomics logo

CEO

- -
25 - 100
- -
$5M - 25M
  • - -
    $5M - 25M
  • 25 - 100
    - -
  • $5M - 25M
  • - -
  • 25 - 100
  • - -
  • $5M - 25M
View ProfileView
2
PierianDx's Competitor - Verogen logo

Brett William

President & CEO

90/100
25 - 100
- -
$5M - 25M
  • - -
    $5M - 25M
  • 25 - 100
    - -
  • $5M - 25M
  • 90/100
  • 25 - 100
  • - -
  • $5M - 25M
View ProfileView
3
PierianDx's Competitor - Swift logo

CEO

- -
25 - 100
$34.8M
$5M - 25M
  • $34.8M
    $5M - 25M
  • 25 - 100
    $34.8M
  • $5M - 25M
  • - -
  • 25 - 100
  • $34.8M
  • $5M - 25M
View ProfileView
4
PierianDx's Competitor - GenapSys logo

Jason Myers

CEO

85/100
100 - 250
$313.7M
$5M - 25M
  • $313.7M
    $5M - 25M
  • 100 - 250
    $313.7M
  • $5M - 25M
  • 85/100
  • 100 - 250
  • $313.7M
  • $5M - 25M
View ProfileView
5
PierianDx's Competitor - PacBio logo

Christian O. Henry

President & CEO

89/100
730
$797.5M
$308M
  • $797.5M
    $308M
  • 730
    $797.5M
  • $308M
  • 89/100
  • 730
  • $797.5M
  • $308M
View ProfileView
PierianDx's top 22 competitors are RTL Genomics, Verogen, Swift, CosmosID, GenapSys, PacBio, Myriad, Oxford Nanopore, HLI, Fabric Genomics, Syapse, Curoverse, DNAnexus, Ambry, Personalis, Genestack, Knome, Roche, Strand Life Sciences, Spiral Genetics, Partek Incorporated and InterpretOmics. Together they have raised over 11.9B between their estimated 112.6K employees. PierianDx's revenue is the ranked 12th among it's top 10 competitors. The top 10 competitors average 3.4B. PierianDx has 120 employees and is ranked lowest among it's top 10 competitors. The top 10 competitors average 4,903.

PierianDx VS RTL Genomics

RTL Genomics is the biggest rival of PierianDx. RTL Genomics was founded in 2004, and its headquarters is in Lubbock, Texas. RTL Genomics operates in the Biotechnology industry. RTL Genomics has 80 fewer employees than PierianDx.

PierianDx VS Verogen

Verogen has been one of PierianDx's top competitors. Verogen is a Private company that was founded in San Diego, California in 2017. Verogen is in the Health Care Technology industry. Verogen has 70 fewer employees vs. PierianDx.

PierianDx VS Swift

Swift is PierianDx's #3 rival. Swift was founded in 2013 in Ann Arbor, Michigan. Swift is in the Biotechnology field. Swift generates $7.1M less revenue than PierianDx.

Looking for similar companies to PierianDx?

Similar Companies

Biotechnology companies in St. Louis

See 21 companies 
Companies in St. Louis with employees in 100-250 range

See 84 companies 
Pharmaceuticals & Biotechnology companies in St. Louis

See 28 companies 
Biotechnology companies in Greater St. Louis Metropolitan Area

See 99 companies 
Biotechnology companies in Missouri

See 143 companies 
Pharmaceuticals & Biotechnology companies in Greater St. Louis Metropolitan Area

See 159 companies 
Pharmaceuticals & Biotechnology companies in Missouri

See 235 companies 
Companies in St. Louis with revenue in $5.0-25M range

See 481 companies 
Biotechnology companies with employees in 100-250 range

See 1,110 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for PierianDx and PierianDx's Competitors

April 30, 2025GlobeNewswire
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics testing and precision medicine, today announced that its Board of Directors has...
April 30, 2025Pharmabiz
Roche announced that the US Food and Drug Administration (FDA) granted Breakthrough Device Designation for the VENTANA TROP2 (EPR20043) RxDx Device....
Today 1:00 PMPacBio Blog
As one of China's most prominent clinical genomics companies, Berry Genomics has a sharp focus on the prevention of genetic birth defects. Their team...
April 29, 2025Benzinga
SALT LAKE CITY, April 29, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostic testing and precision medicine...
April 30, 2025Bio-IT World
Bio-IT World | PacBio this week announced it is licensing advanced DNA methylation detection methods developed by Professor Dennis Lo and colleagues at...
April 30, 2025StreetInsider
Positive recommendation based on clinical, real-world and bioequivalence data supporting feasibility and safety of Phesgos administration outside of c...
April 30, 2025Medthority
If approved, administration of Phesgo outside of a clinical setting (such as in a person's home) by a healthcare professional will be possible, once sa...

Frequently Asked Questions about PierianDx

  1. Who are PierianDx's top competitors?

    PierianDx's top 3 competitors are RTL Genomics, Verogen, Swift.

  2. Who is similar to PierianDx?

    RTL Genomics is the most similar to PierianDx. Verogen and Swift are also similar to PierianDx.

  1. Are PierianDx and RTL Genomics competitors?

    Yes, RTL Genomics is one of PierianDx’s top competitors.